20105 results for «»

Filter By

20105 results

Innovative solutions in complex coronary lesions - Part 1

18 May 2022 – From EuroPCR 2022

Consult this session to discover some innovative solutions in complex coronary lesions, such as: revascularisation for a case with ULMCA and RCA calcification CTO, stentless treatment for left main quadrifurcation lesion, OCT-guided PCI with intravascular lithotripsy in a calcified SVG, and more!

Innovative solutions in complex coronary lesions

How should we treat low risk patients with aortic stenosis?

10 Feb 2021

Watch the replay of this PCR Webinar on TAVI with N. Dumonteil, T. Modine and S. Bleiziffer

How should we treat low risk patients with aortic stenosis?

How should the clinical data on TAVI durability impact the clinical practice?

11 Mar 2021

View the replay of this PCR Webinar on TAVI with L. Sondergaard, D. Capodanno, M. Reardon.

How can we optimise coronary access after TAVI?

Transcatheter Mitral Valve-in-Valve: a safe alternative for an increasing patient population

10 Dec 2020

Discover the replay of this webinar on TAVI with B. Prendergast, S. Berti, S. Redwood and A. Unbehaun.

Transcatheter Mitral Valve-in-Valve: a safe alternative for an increasing patient population

How should I treat a patient with symptomatic AS using the THV Portico device with the FlexNav delivery system

20 Oct 2020

Discover the replay of this webinar on TAVI with G. Manoharan, F. Bedogni and L. Sondergaard.

Patient with symptomatic AS using the THV Portico device

Innovative solutions in complex coronary lesions - Part 2

18 May 2022 – From EuroPCR 2022

Consult this session to learn about innovative solutions in complex coronary lesions, thanks to a variety of cases such as: PCI in a patient with absolute contraindication to contrast administration, another kiss in bifurcation, unexplained hypotension and a new mass, and more!

Innovative solutions in complex coronary lesions

TAVI - Aortic Valve Disease

12 Aug 2022

Chief coordinators:Bernard Prendergast

Interventional cardiologist / Cardiologist

Cleveland Clinic London - London, United Kingdom

Lars Sondergaard

Industry(Incl. R&D)

Abbott Structural Heart - Santa Clara, United States of America

 Management of a patient with an aortic valve disease

TAVI in bicuspid aortic valve disease

03 Nov 2019

View thereplay of this webinar on TAVI in bicuspid aortic valve disease, with Bernard Prendergast, Markus Kasel and Won-Keun Kim.

TAVI in bicuspid aortic valve disease

TAVI and Coronary access

19 Nov 2019

Discover the replay of this webinar on TAVI and Coronary access, with Lars Sondergaard, Giuseppe Tarantini and Thierry Lefevre

TAVI in bicuspid aortic valve disease

TAVI - Aortic Stenosis

12 Aug 2022

Chief coordinator:Nicolas Dumonteil@nicolasdumonte1

Interventional cardiologist / Cardiologist

CLINIQUE PASTEUR - Toulouse, France

 Management of a patient with an aortic stenosis

Innovative solutions in complex coronary lesions - Part 3

18 May 2022 – From EuroPCR 2022

Watch these videos to discover some innovative solutions in complex coronary lesions, thanks to a selection of cases: a 27-year-old woman with STEMI and multiple culprit lesions, an unusual communication between aorta and the heart, CTO RCA done with retrograde approach with reverse CART technique, and more!

Innovative solutions in complex coronary lesions

What are the remaining limitations of TAVI?

07 Jun 2018

View thereplay of this webinar on TAVI with N. Dumonteil, A. S. Petronio and D. Blackman.

What are the remaining limitations of TAVI?

Evaluating the Use of RenalGuard to Protect Patients at High Risk of AKI - STRENGTH Study

14 Aug 2022

The STRENGTH study is a multicentre prospective randomised trial investigating whether RenalGuard is superior to standard intravenous hydration in preventing contrast induced nephropathy in patients with chronic kidney disease (CKD) undergoing complex cardiovascular procedures.

Nicola Ryan

Reviewer

Nicola Ryan
Evaluating the Use of RenalGuard to Protect Patients at High Risk of AKI - STRENGTH Study

Durable polymer vs. biodegradable polymer DES in patients with ACS undergoing complex PCI: A post hoc analysis of the HOST-REDUCE-POLYTECH-ACS trial

30 Aug 2022

The HOST-REDUCE-POLYTECH-ACS trial was a randomised, parallel-group multicentre trial with a 2x2 factorial design testing two independent hypotheses, one of which was the non-inferiority of durable polymer drug-eluting stents (DP-DES) to biodegradable polymer drug-eluting stents (BP-DES) in patients with ACS. In this post-hoc analysis, the authors...

Nicola Ryan

Reviewer

Nicola Ryan
A post hoc analysis of the HOST-REDUCE-POLYTECH-ACS trial

PFO closure in 2019 – Who, Why and How?

20 Jul 2022

View this replay of a LIVE Round Table Webinar - PFO closure in 2019 – Who, Why and How?, with P. Calvert, C. Grasso and P. Lurz

PCR Webinar on Demand: PFO closure in 2019 – Who, Why and How?

Raghav Aggarwal

Ghaziabad, Uttar Pradesh, India

Richa Agrawal

Delhi, India

Structural Heart Disease pre-procedural sizing and planning tutorials: TAVR / TAVI

17 Aug 2022

In this series of tutorials, Gilbert Tang proposes instruction videos on how to use 3mensio for pre-procedural sizing and planning in TAVR, Valve-in-Valve, re-do TAVR, alternate access and more.

pre-procedural sizing and planning tutorials

Mahesh Ahire

Nashik, India

Khalil Ahmed

Karachi, Pakistan

Didn’t find what you were looking for?